¿Terminará RFK con alguna aprobación de vacunas para el 31 de diciembre?
Sí
$7,093 Vol.
$7,093 Vol.
Dec 31, 2025
Reglas
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Creado en: Sep 3, 2025, 11:16 PM ET
Volumen
$7,093Fecha de finalización
Dec 31, 2025Creado en
Sep 3, 2025, 11:16 PM ETResolver
0x65070BE91...Resultado propuesto: No
Sin disputa
Resultado final: No
¿Terminará RFK con alguna aprobación de vacunas para el 31 de diciembre?
Sí
$7,093 Vol.
$7,093 Vol.
Dec 31, 2025
Acerca de
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volumen
$7,093Fecha de finalización
Dec 31, 2025Creado en
Sep 3, 2025, 11:16 PM ETResolver
0x65070BE91...Resultado propuesto: No
Sin disputa
Resultado final: No
Ten cuidado con los enlaces externos.
Ten cuidado con los enlaces externos.

Ten cuidado con los enlaces externos.
Ten cuidado con los enlaces externos.